AnalystsLucas WardLucas Ward's Stock Forecasts
AnalystsLucas Ward
Analyst Ranking
Bottom 2%
#4998 out of 5081 analysts
Average Return
-30.19%
Win Rate
25%6 out of 24
Risk vs Reward
Poor
Good
Lucas Ward's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Liqtech International IncLIQT | +56.25% | $1.50 | $2.35 | 2025-06-15 - 2025-10-29 | Buy |
Liqtech International IncLIQT | +48.73% | $1.58 | $2.35 | 2025-04-06 - 2025-10-29 | Buy |
Vivos Therapeutics IncVVOS | +40.00% | $3.05 | $4.27 | 2024-08-19 - 2025-08-19 | Buy |
Liqtech International IncLIQT | +35.06% | $1.74 | $2.35 | 2024-11-24 - 2025-10-29 | Buy |
Heartsciences IncHSCS | +24.66% | $2.94 | $3.67 | 2024-09-22 - 2025-09-22 | Buy |
Lucas Ward Analyst Color
Get additional color on Lucas Ward's coverage of popular stocks
Lucas Ward's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Heartsciences IncHSCS | 3 | Buy | $9.00 | +203.03% | Maintains | a month ago |
Aclarion IncACON | 4 | Buy | $22.00 | +179.19% | Maintains | a month ago |
Vivos Therapeutics IncVVOS | 4 | Buy | $6.50 | +143.45% | Maintains | 2 months ago |
60 Degrees Pharmaceuticals IncSXTP | 3 | Buy | $3.00 | +114.29% | Maintains | 2 months ago |
Liqtech International IncLIQT | 5 | Buy | $3.60 | +53.19% | Maintains | 4 months ago |
Cyclo Therapeutics IncCYTH | 2 | Buy | $0.95 | N/A | Maintains | a year ago |
Vision Marine Technologies IncVMAR | 2 | Buy | $2,700.00 | N/A | Maintains | a year ago |
Shiftpixy IncPIXY | 1 | Buy | $2,160.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.